A detailed history of Farther Finance Advisors, LLC transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 698 shares of TMCI stock, worth $2,114. This represents 0.0% of its overall portfolio holdings.

Number of Shares
698
Previous 4,717 85.2%
Holding current value
$2,114
Previous $27.7 Million 83.11%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 14, 2025

SELL
$5.34 - $7.7 $21,461 - $30,946
-4,019 Reduced 85.2%
698 $4.68 Million
Q2 2025

Jul 11, 2025

BUY
$5.44 - $8.32 $25,660 - $39,245
4,717 New
4,717 $27.7 Million
Q2 2024

Jul 31, 2024

BUY
$4.17 - $12.62 $404 - $1,224
97 Added 122.78%
176 $1.14 Million
Q1 2024

May 13, 2024

SELL
$11.48 - $15.86 $229 - $317
-20 Reduced 20.2%
79 $988,000
Q4 2023

Feb 14, 2024

BUY
$6.03 - $12.88 $596 - $1,275
99 New
99 $1.26 Million

Others Institutions Holding TMCI

About TREACE MEDICAL CONCEPTS, INC.


  • Ticker TMCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 55,403,300
  • Market Cap $168M
  • Description
  • Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...
More about TMCI
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.